Arduini, D., Ciccarese, C., Acunzo, A., Perrino, M., Maruzzo, M., Verzoni, E., Accettura, C., Bonomi, L., Buttigliero, C., Cremante, M., Pipitone, S., Scartozzi, M., Masini, C., Mollica, V., Primi, F., Strusi, A., Buti, S., Zucali, P. A., Fantinel, E., Iacovelli, R. (2025). Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.551